1. Adams, J., 2018. Surgeon General’s advisory on naloxone and opioid overdose. 〈https://www.surgeongeneral.gov/priorities/opioid-overdose-prevention/naloxone-advisory.html?Utm_campaign=Rx%20Summit&utm_source=hs_email&utm_medium=email&utm_content=62033785&_hsenc=p2ANqtz-8gpzM8wnU94-xrgcG7DYAAHY1MnbgWJF3myPsEulzbdDQs69aij2OvVDKkL7AKwib7B_jhdNfTpXzTB4mrs0P2RvYXg&_hsmi=62033785〉. (Last Accessed May 2018).
2. A role for AMPA receptors in mood disorders;Alt;Biochem. Pharmacol.,2006
3. Anson, P., 2016. AMA Drops pain as vital sign. 〈https://www.painnewsnetwork.org/stories/2016/6/16/ama-drops-pain-as-vital-sign〉. (Last Accessed May 2018).
4. Use of naloxone spray 4 mg in the community setting: a survey of use by community organizations;Avetian;Curr. Med. Res. Opin.,2017
5. Blau, M., 2018. The next naloxone? Companies, academics search for better overdose-reversal drugs. 〈https://www.statnews.com/2018/04/10/next-naloxone-overdose-reversal-drugs/〉. (Last Accessed May 2018).